{"DataElement":{"publicId":"3652991","version":"1","preferredName":"Anaplastic Lymphoma Kinase Cell Outcome","preferredDefinition":"the outcome related to the results of anaplastic lymphoma kinase (ALK) testing.","longName":"ALKClTtOtcm","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"3028536","version":"1","preferredName":"Anaplastic Lymphoma Kinase Cells","preferredDefinition":"The 2;5 chromosomal translocation is frequently associated with anaplastic large cell lymphomas (ALCLs). The translocation creates a fusion gene consisting of the ALK (anaplastic lymphoma kinase) gene and the nucleophosmin (NPM) gene: the 3' half of ALK, derived from chromosome 2, is fused to the 5' portion of NPM from chromosome 5. A recent study shows that the product of the NPM-ALK fusion gene is oncogenic. The deduced amino acid sequences reveal that ALK is a novel receptor protein-tyrosine kinase having a putative transmembrane domain and an extracellular domain. These sequences are absent in the product of the transforming NPM-ALK gene._The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","longName":"ALK_CELL","context":"SPOREs","contextVersion":"2.31","ObjectClass":{"publicId":"3028516","version":"1","preferredName":"Anaplastic Lymphoma Kinase","preferredDefinition":"The 2;5 chromosomal translocation is frequently associated with anaplastic large cell lymphomas (ALCLs). The translocation creates a fusion gene consisting of the ALK (anaplastic lymphoma kinase) gene and the nucleophosmin (NPM) gene: the 3' half of ALK, derived from chromosome 2, is fused to the 5' portion of NPM from chromosome 5. A recent study shows that the product of the NPM-ALK fusion gene is oncogenic. The deduced amino acid sequences reveal that ALK is a novel receptor protein-tyrosine kinase having a putative transmembrane domain and an extracellular domain. These sequences are absent in the product of the transforming NPM-ALK gene.","longName":"C27032","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ALK Tyrosine Kinase Receptor","conceptCode":"C27032","definition":"ALK tyrosine kinase receptor (1620 aa, ~176 kDa) is encoded by the human ALK gene. This protein is involved in ligand binding, tyrosine phosphorylation and signal transduction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"822BAC66-A5A6-B260-E040-BB89AD432869","latestVersionIndicator":"Yes","beginDate":"2010-03-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-19","modifiedBy":"SBREXT","dateModified":"2020-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2499419","version":"1","preferredName":"Cell","preferredDefinition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid. Cells are highly variable and specialized in both structure and function, though all must at some stage replicate proteins and nucleic acids, utilize energy, and reproduce themselves.","longName":"C12508","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"197C88F5-7C01-37BE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-26","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-26","modifiedBy":"ONEDATA","dateModified":"2006-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"822D6D9C-B362-E619-E040-BB89AD4368AA","latestVersionIndicator":"Yes","beginDate":"2010-03-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Corrected typographical error introduced from error in definition of ALK from EVS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3652213","version":"1","preferredName":"Anaplastic Lymphoma Kinase Cell Outcome","preferredDefinition":"the outcome related to the results of anaplastic lymphoma kinase (ALK) testing.","longName":"ALKClTtOc","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"80","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Positive for known pathogenic mutation","valueDescription":"Positive for known pathogenic mutation","ValueMeaning":{"publicId":"3652217","version":"1","preferredName":"Positive for known pathogenic mutation","longName":"3652217","preferredDefinition":"Positive for known pathogenic mutation","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D34A62CF-F8C4-0130-E040-BB89AD430CDB","latestVersionIndicator":"Yes","beginDate":"2013-01-14","endDate":null,"createdBy":"CORRALC","dateCreated":"2013-01-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3E5E1D1-D3FB-EE50-E040-BB89AD435A42","beginDate":"2013-01-14","endDate":null,"createdBy":"CORRALC","dateCreated":"2013-01-22","modifiedBy":"ONEDATA","dateModified":"2013-01-22","deletedIndicator":"No"},{"value":"Positive for variant of unknown significance","valueDescription":"Positive for variant of unknown significance","ValueMeaning":{"publicId":"3652216","version":"1","preferredName":"Positive for variant of unknown significance","longName":"3652216","preferredDefinition":"Positive for variant of unknown significance","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D34A62CF-F8A1-0130-E040-BB89AD430CDB","latestVersionIndicator":"Yes","beginDate":"2013-01-14","endDate":null,"createdBy":"CORRALC","dateCreated":"2013-01-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3E5E1D1-D40F-EE50-E040-BB89AD435A42","beginDate":"2013-01-14","endDate":null,"createdBy":"CORRALC","dateCreated":"2013-01-22","modifiedBy":"ONEDATA","dateModified":"2013-01-22","deletedIndicator":"No"},{"value":"Positive for likely benign variant","valueDescription":"Positive for likely benign variant","ValueMeaning":{"publicId":"3652215","version":"1","preferredName":"Positive for likely benign variant","longName":"3652215","preferredDefinition":"Positive for likely benign variant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D34A62CF-F87E-0130-E040-BB89AD430CDB","latestVersionIndicator":"Yes","beginDate":"2013-01-14","endDate":null,"createdBy":"CORRALC","dateCreated":"2013-01-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3E5E1D1-D423-EE50-E040-BB89AD435A42","beginDate":"2013-01-14","endDate":null,"createdBy":"CORRALC","dateCreated":"2013-01-22","modifiedBy":"ONEDATA","dateModified":"2013-01-22","deletedIndicator":"No"},{"value":"Negative for mutations in the ALK kinase domain","valueDescription":"Negative for mutations in the ALK kinase domain","ValueMeaning":{"publicId":"3652214","version":"1","preferredName":"Negative for mutations in the ALK kinase domain","longName":"3652214","preferredDefinition":"Negative for mutations in the ALK kinase domain","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D34A62CF-F85B-0130-E040-BB89AD430CDB","latestVersionIndicator":"Yes","beginDate":"2013-01-14","endDate":null,"createdBy":"CORRALC","dateCreated":"2013-01-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3E5E1D1-D437-EE50-E040-BB89AD435A42","beginDate":"2013-01-14","endDate":null,"createdBy":"CORRALC","dateCreated":"2013-01-22","modifiedBy":"ONEDATA","dateModified":"2013-01-22","deletedIndicator":"No"},{"value":"Unsatisfactory","valueDescription":"UNSATISFACTORY","ValueMeaning":{"publicId":"2560408","version":"1","preferredName":"UNSATISFACTORY","longName":"2560408","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Meeting a quantitative or qualitative measure necessary for a requirement; enough to meet the needs of a situation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sufficient","conceptCode":"C63351","definition":"Meeting a quantitative or qualitative measure necessary for a requirement; enough to meet the needs of a situation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B905-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"HARTLEYG","dateModified":"2016-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3E5E1D1-D441-EE50-E040-BB89AD435A42","beginDate":"2013-01-14","endDate":null,"createdBy":"CORRALC","dateCreated":"2013-01-22","modifiedBy":"ONEDATA","dateModified":"2013-01-22","deletedIndicator":"No"},{"value":"Not performed","valueDescription":"Not performed","ValueMeaning":{"publicId":"2618215","version":"1","preferredName":"Not performed","longName":"2618215","preferredDefinition":"Not performed","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2CB2A5A6-290D-6B1F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-27","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-03-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3E5E1D1-D44B-EE50-E040-BB89AD435A42","beginDate":"2013-01-14","endDate":null,"createdBy":"CORRALC","dateCreated":"2013-01-22","modifiedBy":"ONEDATA","dateModified":"2013-01-22","deletedIndicator":"No"},{"value":"Negative for activating variant in ALK tyrosine kinase domain","valueDescription":"Negative for activating variant in ALK tyrosine kinase domain","ValueMeaning":{"publicId":"5775924","version":"1","preferredName":"Negative for activating variant in ALK tyrosine kinase domain","longName":"5775924","preferredDefinition":"Negative for activating variant in ALK tyrosine kinase domain","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D27D05E-B7D2-4632-E053-F662850AB394","latestVersionIndicator":"Yes","beginDate":"2017-04-14","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D27D05E-B7EB-4632-E053-F662850AB394","beginDate":"2017-04-14","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-14","modifiedBy":"ONEDATA","dateModified":"2017-04-14","deletedIndicator":"No"},{"value":"Positive for activating variant in ALK tyrosine kinase domain","valueDescription":"Positive for activating variant in ALK tyrosine kinase domain","ValueMeaning":{"publicId":"5775925","version":"1","preferredName":"Positive for activating variant in ALK tyrosine kinase domain","longName":"5775925","preferredDefinition":"Positive for activating variant in ALK tyrosine kinase domain","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D27D05E-B7F5-4632-E053-F662850AB394","latestVersionIndicator":"Yes","beginDate":"2017-04-14","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D27D05E-B80E-4632-E053-F662850AB394","beginDate":"2017-04-14","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-14","modifiedBy":"ONEDATA","dateModified":"2017-04-14","deletedIndicator":"No"},{"value":"No variants identified","valueDescription":"No variants identified","ValueMeaning":{"publicId":"5796799","version":"1","preferredName":"No variants identified","longName":"5796799","preferredDefinition":"No variants identified","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E3F999C-040D-2ABA-E053-F662850A2FC6","latestVersionIndicator":"Yes","beginDate":"2017-04-28","endDate":null,"createdBy":"DAVISJ","dateCreated":"2017-04-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4E3F999C-0426-2ABA-E053-F662850A2FC6","beginDate":"2017-04-28","endDate":null,"createdBy":"DAVISJ","dateCreated":"2017-04-28","modifiedBy":"ONEDATA","dateModified":"2017-04-28","deletedIndicator":"No"},{"value":"Not done","valueDescription":"Not done","ValueMeaning":{"publicId":"5501320","version":"1","preferredName":"Not done","longName":"5501320v1.00","preferredDefinition":"Indicates a task, process or examination that has either not been initiated or not been completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3DFE640E-6DFA-26CB-E053-F662850A75D1","latestVersionIndicator":"Yes","beginDate":"2016-10-03","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-10-03","modifiedBy":"KUMMEROA","dateModified":"2023-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D269714-3E77-1B40-E053-F662850AB57D","beginDate":"2017-04-14","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-14","modifiedBy":"ONEDATA","dateModified":"2017-04-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2476191","version":"1","preferredName":"Result","preferredDefinition":"Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"11CE3EF3-93C8-1DC4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"ONEDATA","dateModified":"2006-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D34A62CF-F81E-0130-E040-BB89AD430CDB","latestVersionIndicator":"Yes","beginDate":"2013-01-14","endDate":null,"createdBy":"CORRALC","dateCreated":"2013-01-14","modifiedBy":"DAVISJ","dateModified":"2017-04-28","changeDescription":"Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"ALK Sequencing Results","type":"Preferred Question Text","description":"ALK Sequencing Results","url":null,"context":"CTEP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"ALK sequencing tumor results:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D371C662-FCA9-597C-E040-BB89AD431F1C","latestVersionIndicator":"Yes","beginDate":"2013-01-16","endDate":null,"createdBy":"CORRALC","dateCreated":"2013-01-16","modifiedBy":"HLAINGY","dateModified":"2017-04-14","changeDescription":" Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}